| ID: | 133 | |
|---|---|---|
| Name: | Compound 133 | |
| Description: | Original numeration in publication: 17 | |
| Labels: | Training_set, Thiazolidine‐2, 4‐dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C19H14Cl2N2O4S/c1-27-14-6-4-13(5-7-14)22-17(24)10-23-18(25)16(28-19(23)26)8-11-2-3-12(20)9-15(11)21/h2-9H,10H2,1H3,(H,22,24)/b16-8- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.49 |
El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491 |
| 6.04417 |
Eq1: VEGFR-2 inhibition (Data used to train model) |